FGFR3 and bladder papillary urothelial carcinoma: For example, certain mutations, such as that of FGFR3, are found in approximately 75% of low‐grade papillary bladder urothelial carcinoma, while overexpression of the FGFR3 protein is associated with high‐grade, aggressive disease.6, 7